Improving Access to Patient-Centered Drug-Resistant Tuberculosis Management Services in Ethiopia
Improving Access to Patient-Centered Drug-Resistant Tuberculosis Management Services in Ethiopia
Despite the progress made so far, drug-resistant TB (DR-TB) case finding remains inadequate and low. One of the main enduring challenges is the insufficient implementation of first-line and second-line drug susceptibility testing, resulting in the number of DR-TB patients that are detected and enrolled in treatment falling consistently below expectations. This technical brief explores how the USAID Eliminate TB Project team is helping hospitals in Ethiopia improve this vital function.